Pfizer TLZ 0.25 Pill - white capsule-shape
Generic Name: talazoparib
Pill with imprint Pfizer TLZ 0.25 is White, Capsule-shape and has been identified as Talzenna 0.25 mg. It is supplied by Pfizer Inc.
Talzenna is used in the treatment of Breast Cancer; Prostate Cancer and belongs to the drug class PARP inhibitors. Talzenna 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer TLZ 0.25
Talzenna
- Generic Name
- talazoparib
- Imprint
- Pfizer TLZ 0.25
- Strength
- 0.25 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- PARP inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0296
More about Talzenna (talazoparib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PARP inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.